Our Entrepreneurs

Christopher Whitfield

Batswadi Pharmaceuticals

Christopher Whitfield Christopher Whitfield
“I saw an opportunity to transform the pharmaceutical industry in South Africa.”
Country
South Africa
Industry
Healthcare
Year selected
2007
Website

Company Snapshot

Christopher founded Batswadi Pharmaceuticals in October 2005 as a specialist healthcare company focusing on four core business areas: pharmaceuticals, diagnostics, research and development, and consumer health. After jump-starting the company by leading a management buy-out of Eli Lilly’s insulin portfolio in South Africa, Christopher has quickly built Batswadi into a diversified company with significant potential. As the only black-empowered (majority-owned by historically disadvantaged South Africans) pharmaceutical company in South Africa, Batswadi is a rising star.

Endeavor and Batswadi Pharmaceuticals

Christopher is actively receiving guidance in the areas of fundraising and branding. In addition to local support, he has benefited from the Global eMBA and G-Lab programs, and an Immersion Tour.

Christopher has been on the Endeavor South Africa board since 2008, and serves as a local panelist.

From the Entrepreneurship Blog

Events

Endeavor Investor Network's Latin American Venture Forum Gathers 160+ Entrepreneurs and Investors in Bogotá

September 16th, 2014 — by admin

Last week, Endeavor Global and Endeavor Colombia hosted the inaugural Latin American Venture Forum in partnership with Bancoldex. This event gathered over 30 of the most active regional funds in Colom…

Read more

In the news

Greece's Hellas Direct Named a National Champion by the European Business Awards

September 22nd, 2014 — by admin

The European Business Awards, an annual honor that recognizes innovation and ethics in the regional business community, recently named Greece's Hellas Direct to its rankings. Along with a selection of…

Read more

Contact us

Press center

Community

Newsletter Sign Up